Generic Pharmaceuticals and Patents

This blog is related to the various litigations related to patents w.r.t pharma industry.

Saturday, January 22, 2011

Byetta (exenatide injection) approved by Health Canada for the treatment of type 2 diabetes

›
Jan. 17 - Eli Lilly Canada Inc. is pleased to announce the Health Canada approval of BYETTATM (exenatide injection) for the treatment of adu...

Novo Nordisk Intends to Appeal Adverse Ruling in Prandin (repaglinide) Patent Case

›
Jan. 19, 2011 - Today, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an ...

Dr. Reddy's and other four generic players got final approval for Pantoprazole Sodium Delayed-Released Tablets

›
Jan 20, 2011 - Dr. Reddy's Laboratories today announced that it has launched Pantoprazole Sodium Delayed-Released tablets (20mg and 40mg...
Saturday, December 25, 2010

Dear Subscribers

›
I was not blogging since long time, but now i will update this blog every week. Sorry for such a long gap. Regards, Amit
Tuesday, April 27, 2010

Watson Says Appeals Court Affirms Concerta Patent Invalid

›
Watson Pharmaceuticals, Inc. today confirmed that the U.S. Court of Appeals for the Federal Circuit Court has affirmed a March 31, 2009 Dist...
1 comment:

Shire Receives INTUNIV Paragraph IV Notice Letter From Anchen

›
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Anchen Pharmaceu...

Actavis Launches Generic Version of Flomax In The U.S.

›
Actavis Inc., today began shipping Tamsulosin capsules to its customers in the United States. The generic equivalent to FlomaxĂ‚®, Tamsulosin...
Monday, April 26, 2010

Heartburn for Sun Pharma and Teva in the US

›
Mumbai: Sun Pharmaceuticals and Teva received a blow after a US federal jury ruled that Pfizer Inc and Altana AG have valid patents for acid...
Wednesday, January 27, 2010

Break from Blogging

›
Dear Subscribers, I am taking break from blogging for about a month due to involvement in some other projects. I am sorry for this break. en...
1 comment:
Wednesday, January 20, 2010

Court Finds J&J Patents Invalid

›
Boston Scientific Corporation announced today that the U.S. District Court for the District of Delaware has found all four patents in a suit...
Tuesday, January 12, 2010

Suven receives 2 product patents in China & Russia

›
Suven Life Sciences Ltd (SUVEN) announces that two product patents were granted in China (100378108 and 100378109) and Russia (2325392 and 2...

India’s clinical expertise & quality of sites impress CDER, US FDA: Dr Steve Wilson

›
India’s clinical acumen and quality of healthcare infrastructure designated to conduct human studies are two key parameters which have impre...

Bal Pharma on major export drive, targets regulated markets for APIs, formulations

›
Bal Pharma, the medium-sized pharma company in Karnataka is on an export over drive mode. The company is looking at expanding its internatio...

Patent office begins data compilation on 'working patents' in India

›
For the first time in the history of patents in the country, the government has started the gargantuan process of compilation of data regard...
Monday, January 11, 2010

MAP Pharmaceuticals Announces FDA Will Not Require a Second Pivotal Efficacy Study for Levadex NDA Submission

›
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal ef...
›
Home
View web version
Powered by Blogger.